fluorodeoxyglucose f18 has been researched along with butylscopolammonium bromide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avril, N; Schwaiger, M; Stahl, A; Weber, WA | 1 |
| Yamamoto, F | 1 |
| Asaka, M; Nakada, K; Satoh, M; Tamaki, N; Yamamoto, F; Zhao, S | 1 |
| Chambers, J; Emmott, J; Sanghera, B; Wong, WL | 1 |
| Chambers, J; Emmott, J; Sanghera, B; Wellsted, D; Wong, WL | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and butylscopolammonium bromide
| Article | Year |
|---|---|
The effects of N-butylscopolamine on bowel uptake: an 18F-FDG PET study.
Topics: Adult; Aged; Aged, 80 and over; Butylscopolammonium Bromide; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Intestinal Absorption; Intestinal Mucosa; Intestines; Male; Middle Aged; Muscarinic Antagonists; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Influence of N-butylscopolamine on SUV in FDG PET of the bowel.
Topics: Aged; Antidiarrheals; Blood Glucose; Body Weights and Measures; Butylscopolammonium Bromide; Female; Fluorodeoxyglucose F18; Humans; Intestinal Mucosa; Intestines; Male; Middle Aged; Positron-Emission Tomography | 2009 |
3 other study(ies) available for fluorodeoxyglucose f18 and butylscopolammonium bromide
| Article | Year |
|---|---|
Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen.
Topics: Abdomen; Adult; Blood Glucose; Butylscopolammonium Bromide; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Liver; Lymphoma; Lymphoma, Non-Hodgkin; Male; Parasympatholytics; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed | 2000 |
[Study on changes in physiological [18F]fluorodeoxyglucose accumulation in the digestive tube caused by drug treatment].
Topics: Animals; Anti-Ulcer Agents; Butylscopolammonium Bromide; Digestive System; Fluorodeoxyglucose F18; Omeprazole; Peristalsis; Rats; Rats, Sprague-Dawley | 2004 |
Gastrointestinal uptake of FDG after N-butylscopolamine or omeprazole treatment in the rat.
Topics: Animals; Butylscopolammonium Bromide; Drug Combinations; Fluorodeoxyglucose F18; Gastrointestinal Tract; Omeprazole; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2004 |